PharmaCyte Biotech Joins Forces with MyMD Pharmaceuticals with a $7 Million Investment to Revolutionize Inflammatory Disease Therapies
PharmaCyte Biotech Invests $7 Million in MyMD Pharmaceuticals to Develop Novel Therapies for Inflammatory DiseasesPharmaCyte Biotech, a renowned biotechnology company specializing in cellular therapies for various disea...
May 21, 2024
• Biotechnology & Pharmaceuticals Industry
Business Update
Nasdaq
